Oral vinorelbine and capecitabine as first-line therapy in metastatic breast cancer: a retrospective analysis

A retrospective analysis of 70 patients with triple-negative or hormone-resistant advanced breast carcinoma who had not previously received chemotherapy was carried out. Patients received oral vinorelbine 60 mg/m2 on day 1 and 8, plus capecitabine 1000 mg/m2 bid for 14 consecutive days every 3 weeks...

Full description

Bibliographic Details

Published in:	Future Science OA
Main Authors:	Maria Rosaria Valerio, Pietro Spadaro, Concetta Arcanà, Nicolò Borsellino, Calogero Cipolla, Paolo Vigneri, Dario Piazza, Vittorio Gebbia
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2021-12-01
Subjects:	breast carcinoma capecitabine metastases oral chemotherapy vinorelbine
Online Access:	https://www.future-science.com/doi/10.2144/fsoa-2020-0095